Market Alert: Fed Cuts Rates by 25 bps, Signals More to Come

IMEXHS Secures Major Radiology Contract with Oncolife in Colombia.

Sep 26, 2025

IMEXHS Limited (ASX: IME) has signed a significant agreement with Oncolife, a leading cancer-focused healthcare provider in Colombia. The contract covers the delivery of advanced radiology services across Oncolife’s hospital in Bogotá and its centres in Villavicencio and Zipaquira, all of which specialise in oncology care. Under the deal, IMEXHS will deploy its RIS/PACS platform, patient portal, and AI-powered diagnostic tools to support high-complexity diagnostic procedures essential for cancer treatment.

The agreement begins immediately with an initial term of one year and is expected to generate approximately AU$1.4 million in New Annual Recurring Revenue (NARR), combining both services and software. This partnership also reflects IMEXHS’s new pricing structure introduced in 2024, designed to enhance profitability while driving growth. CEO Dr German Arango emphasised that the collaboration reinforces IMEXHS’s leadership in high-complexity radiology and strengthens its strategic presence in Latin America’s specialised healthcare sector.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com